NEW YORK, NY / ACCESSWIRE / June 20, 2016 / Bronstein, Gewirtz & Grossman, LLC, notifies investors of class action against of Neovasc, Inc. ("Neovasc" or "the Company") (
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act").
Neovasc is a specialty medical company that develops cardiovascular products. Neovasc's primary product is the Tiara, a transcatheter mitral valve device used to treat mitral valve disease. This device can be implanted through minimally invasive surgery to patients with mitral regurgitation resulting from mitral heart valve disease.